Connor Leong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Connor Leong has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Aisling Kyne
Carlson College of Veterinary Medicine, Oregon State University
1 shared publication- Dunping Cao
Department of Chemistry, College of Science, Oregon State University, Corvallis, OR 97331, USA
1 shared publication - Jennifer A. Field
Oregon State University
1 shared publication - Lisa Truong
Sinnhuber Aquatic Research Laboratory, Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA
1 shared publication Michael L Kent
Department of Biomedical Sciences, Oregon State University
1 shared publication- Robert L. Tanguay
Department of Environmental and Molecular Toxicology, Sinnhuber Aquatic Research Laboratory, Oregon State University, Corvallis, OR 97333, USA
1 shared publication
Latest Publications
- Open Access
Pseudocapillaria tomentosa Infections in Laboratory Larval and Adult Zebrafish ( Danio rerio ): Development and Advances in an In Vivo Anthelmintic Drug Discovery Model
Parasite resistance is an increasing problem in livestock and companion animals. Developing new drug discovery models may improve the identification of novel anthelmintic drugs which will reduce parasite infections. Adult zebrafish ( Danio rerio ) have been previously used as a model for anthelmintic drug discovery by infecting them with the gastrointestinal nematode Pseudocapillaria tomentosa . Using larval zebrafish will increase assay sensitivity and throughput because this in vivo platform evaluates host parasite interactions and is conducted in multi-well plates. To develop this assay, this study focuses on 1) evaluating infections in 5-30 days post fertilization (dpf) fish, 2) validating the assay with a known anthelmintic used in domestic animals, and 3) documenting the growth and development of P. tomentosa . 30 dpf fish had the most robust infections in multi-well plates and the best survival compared to younger larvae. Assay sensitivity was evaluated by aqueously exposing 30 dpf infected zebrafish to emamectin benzoate (a macrocyclic lactone), which successfully reduced infection intensity. In vitro larvae hatched from eggs, larval, and adult zebrafish (n=488) were used to document P. tomentosa development from 1-37 days post exposure. A change point analysis (CPA) predicted the ecdysis (molting) points as follows (mm): L1/L2 = 0.220, L2/L3 = 0.571, L3/L4 = 1.174, and L4/L5 = 1.584. Identifying the worm molts sizes enables the inclusion of developmental endpoints within trials. Overall, this study will increase the sensitivity of anthelmintic drug discovery because the validated high throughput larval zebrafish model accounts for drug interactions between the host and parasite. Graphical
Open AccessPseudocapillaria tomentosa Infections in Laboratory Larval and Adult Zebrafish ( Danio rerio ): Development and Advances in an In Vivo Anthelmintic Drug Discovery Model
Parasite resistance is an increasing problem in livestock and companion animals. Developing new drug discovery models may improve the identification of novel anthelmintic drugs which will reduce parasite infections. Adult zebrafish ( Danio rerio ) have been previously used as a model for anthelmintic drug discovery by infecting them with the gastrointestinal nematode Pseudocapillaria tomentosa . Using larval zebrafish will increase assay sensitivity and throughput because this in vivo platform evaluates host parasite interactions and is conducted in multi-well plates. To develop this assay, this study focuses on 1) evaluating infections in 5-30 days post fertilization (dpf) fish, 2) validating the assay with a known anthelmintic used in domestic animals, and 3) documenting the growth and development of P. tomentosa . 30 dpf fish had the most robust infections in multi-well plates and the best survival compared to younger larvae. Assay sensitivity was evaluated by aqueously exposing 30 dpf infected zebrafish to emamectin benzoate (a macrocyclic lactone), which successfully reduced infection intensity. In vitro larvae hatched from eggs, larval, and adult zebrafish (n=488) were used to document P. tomentosa development from 1-37 days post exposure. A change point analysis (CPA) predicted the ecdysis (molting) points as follows (mm): L1/L2 = 0.220, L2/L3 = 0.571, L3/L4 = 1.174, and L4/L5 = 1.584. Identifying the worm molts sizes enables the inclusion of developmental endpoints within trials. Overall, this study will increase the sensitivity of anthelmintic drug discovery because the validated high throughput larval zebrafish model accounts for drug interactions between the host and parasite. Graphical
- Open Access
Dietary Perfluorohexanoic Acid (PFHxA) Exposures in Juvenile Zebrafish Produce Subtle Behavioral Effects across Generations
Ubiquitous anthropogenic contaminants of concern, per- and polyfluoroalkyl substances (PFAS) are frequently detected in the environment and human populations around the world. Diet is a predominate route of human exposure, and PFAS are frequently measured in food. Manufacturing trends have shifted from legacy PFAS to shorter-chain alternatives that are suggested to be safer, such as perfluorohexanoic acid (PFHxA). However, the current amount of data to support safety assessments of these alternatives is not yet sufficient. The present study investigated the effects of a 42-day dietary exposure to 1, 10, or 100 ng/g PFHxA in juvenile zebrafish. The zebrafish model was leveraged to interrogate morphometrics, fecundity, and numerous behavior endpoints across multiple generations. Dietary PFHxA exposure did not result in measurable body burden and did not affect growth, fecundity, adult social perception behavior, or associative learning. PFHxA exposure did induce abnormal adult anxiety behaviors in the F0 generation that persisted transgenerationally in the F1 and F2. Abnormal larval and juvenile behavior was observed in the F1 generation, but not in the F2. PFHxA juvenile dietary exposure induced subtle and multigenerational behavior effects that warrant further investigation of this and other alternative short-chain PFAS.
Open AccessDietary Perfluorohexanoic Acid (PFHxA) Exposures in Juvenile Zebrafish Produce Subtle Behavioral Effects across Generations
Ubiquitous anthropogenic contaminants of concern, per- and polyfluoroalkyl substances (PFAS) are frequently detected in the environment and human populations around the world. Diet is a predominate route of human exposure, and PFAS are frequently measured in food. Manufacturing trends have shifted from legacy PFAS to shorter-chain alternatives that are suggested to be safer, such as perfluorohexanoic acid (PFHxA). However, the current amount of data to support safety assessments of these alternatives is not yet sufficient. The present study investigated the effects of a 42-day dietary exposure to 1, 10, or 100 ng/g PFHxA in juvenile zebrafish. The zebrafish model was leveraged to interrogate morphometrics, fecundity, and numerous behavior endpoints across multiple generations. Dietary PFHxA exposure did not result in measurable body burden and did not affect growth, fecundity, adult social perception behavior, or associative learning. PFHxA exposure did induce abnormal adult anxiety behaviors in the F0 generation that persisted transgenerationally in the F1 and F2. Abnormal larval and juvenile behavior was observed in the F1 generation, but not in the F2. PFHxA juvenile dietary exposure induced subtle and multigenerational behavior effects that warrant further investigation of this and other alternative short-chain PFAS.